A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients

Olanzapine has exhibited efficacy as an antiemetic agent when used with 5-HT(3) receptor antagonists, dexamethasone, and NK(1) receptor antagonists for patients receiving highly emetogenic chemotherapy. In addition, several studies have reported the efficacy or safety of olanzapine in patients recei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Nishimura, Junichi, Hasegawa, Akiko, Kudo, Toshihiro, Otsuka, Tomoyuki, Yasui, Masayoshi, Matsuda, Chu, Haraguchi, Naotsugu, Ushigome, Hajime, Nakai, Nozomu, Abe, Tomoki, Hara, Hisashi, Shinno, Naoki, Asukai, Kei, Hasegawa, Shinichiro, Yamada, Daisaku, Sugimura, Keijiro, Yamamoto, Kazuyoshi, Wada, Hiroshi, Takahashi, Hidenori, Omori, Takeshi, Miyata, Hiroshi, Ohue, Masayuki
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7907185/
https://ncbi.nlm.nih.gov/pubmed/33633328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84225-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados